Skip to main content
Premium Trial:

Request an Annual Quote

ABI to Grant SOLiD Services Under Competitive Grant Program

NEW YORK (GenomeWeb News) – As part of a new competitive grant program, Applied Biosystems will provide sequencing services to eleven researchers in academic or institutional labs in order to “inspire new genomic sequencing studies on next-generation sequencing technology,” the company said today.
The $10K Genome Grant Program will give one first-place winner up to 60 gigabases or 750 million tags of sequencing data, and will give ten second place winners one two-slide run. For the first-place winner, ABI will perform the sequencing, primary data generation, and analysis on its SOLiD 3 System. The second place winners will receive the sequencing services either from ABI or one of its SOLiD service program providers.
ABI said it aims to support genomics, epigenomics, and transcriptome studies, and that it is part of the larger efforts of the scientific community to bring down the cost of sequencing a genome to $10,000. The firm also said that by extending SOLiD into other application areas, such as RNA and epigenetic analysis, researchers will be able to advance the use of genomic data for clinical research and personalized medicine.
Grant entries, which are due by Dec. 31, will be reviewed by an international panel of scientists with next-generation sequencing knowledge and ABI officials. The winners will be announced in February 2009.
ABI said it is encouraging scientists to submit a proposal that includes a statement of their underlying project goals, the type and status of the project samples, and availability of bioinformatics resources.
“By lowering the cost of sequencing, researchers will be afforded more opportunities to explore the role of rare genetic variations and examine how they contribute to common ailments," Stefan Schreiber, a member of the panel and a professor of medicine and gastroenterology at the Christian-Albrechts University in Kiel, Germany, said in a statement.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.